Skip to content

NAM Tuberculosis information forum summary online now

Single class therapy may be enough to control HIV in some drug-resistant patients

2NN study shows nevirapine equal to efavirenz, but has better lipid profile

Additional case reports of tenofovir kidney toxicity

Cardiovascular risks of HAART: More data but little more clarity?

No specific mention of AIDS in Mbeki speech as Mandela refuses to endorse TAC demo

Male domination of women hinders HIV prevention

Alpha interferon makes a comeback as HIV treatment

ddI dosing with tenofovir defined